A large number of consumers, who regard themselves as being otherwise ‘healthy’, use various probiotic
products. They do so, on the assumption that probiotics can maintain their health and well-being and
potentially reduce their long-term risk of diseases of the gastrointestinal, urogential tracts, kidney,
respiratory tract and cardiovascular tract. However, although healthy people are the common target for
these new functional food products, the number of clinical trials proving efficacy has until recently been
quite limited. In one sense, unless products are available, then there is nothing to take or to test clinically;
yet on the other hand, when there is a plethora of products calling themselves probiotics, but not
clinically proven, the consumer or healthcare provider is unsure which to take and what to expect from
their use.
A large number of consumers, who regard themselves as being otherwise ‘healthy’, use various probioticproducts. They do so, on the assumption that probiotics can maintain their health and well-being andpotentially reduce their long-term risk of diseases of the gastrointestinal, urogential tracts, kidney,respiratory tract and cardiovascular tract. However, although healthy people are the common target forthese new functional food products, the number of clinical trials proving efficacy has until recently beenquite limited. In one sense, unless products are available, then there is nothing to take or to test clinically;yet on the other hand, when there is a plethora of products calling themselves probiotics, but notclinically proven, the consumer or healthcare provider is unsure which to take and what to expect fromtheir use.
การแปล กรุณารอสักครู่..
